Purpose: To report a case of corneal neovascularization misdiagnosed as total limbal stem cell deficiency (LSCD).
severe thinning at the limbus and peripheral corneal pannus and neovascularization that spared the central cornea, a smooth epithelium without fluorescein staining at the central cornea, an uneven surface, and pooling of fluorescein at the peripheral cornea accompanied by minimal fluorescein staining of the sectoral peripheral epithelium. IVCM showed that epithelial cells in the central cornea exhibited a corneal phenotype and that the morphology of the epithelium in all limbal regions except the nasal limbus was normal. Epithelial cellular density and thickness were within the normal range. AS-OCT showed severe thinning in the limbus and a normal epithelial layer in the cornea and limbus. Based on the findings of IVCM and AS-OCT, we concluded that the patient had minimal LSCD, and limbal stem cell transplantation was not recommended.
Conclusions:
Clinical presentation alone is insufficient to correctly diagnose LSCD in complex cases. Additional diagnostic tests, such as IVCM, are necessary to confirm the diagnosis before any surgical intervention.
Key Words: limbal stem cell deficiency, in vivo confocal microscopy, diagnosis, corneal neovascularization, pannus (Cornea 2018;37:1067-1070) L imbal stem cell deficiency (LSCD) is a disorder caused by dysfunction and/or loss of limbal stem cells. LSCD has been diagnosed mainly based on the medical history and clinical signs, including irregular and opacified corneal epithelium, recurrent epithelial defects, late fluorescein staining, and neovascularization of the cornea. The clinical presentation might not be specific to LSCD in complex cases. The recent finding that residual limbal epithelial cells could be present in the eyes with clinical presentation of total LSCD 1 indicates that it is challenging to assess the severity accurately based on of clinical presentation alone. In this study, we report a case of corneal neovascularization and scleritis that was misdiagnosed as total LSCD at several major tertiary eye care centers in the United States.
CASE PRESENTATION
A 61-year-old woman with a history of bilateral scleritis, keratitis, and uveitis for more than 20 years presented to the Stein Eye Institute from New York City to undergo allogeneic keratolimbal transplantation. Previous extensive workups for autoimmune diseases were negative. She was treated with short courses of systemic mycophenolate mofetil, cyclosporine, and daclizumab. Because of side effects, systemic treatments were stopped. She had not undergone any systemic immunosuppressive therapy for many years. Two years ago, she had globe rupture from a minor self-inflicted injury due to severe scleral thinning in her right eye. Chronic inflammation and exudative retinal detachment occurred after trauma, and she lost most of her vision in the right eye. Her left eye was her functional eye for most of her life. Although long-term keratitis eventually led to stromal scarring, she maintained visual acuity of counting fingers after cataract surgery, which was performed several years ago. Total LSCD in her left eye was diagnosed by experienced corneal specialists 1 year ago, and she was confirmed as a candidate for limbal stem cell transplantation (LSCT) at 3 tertiary eye care centers and for Boston type I keratoprosthesis implantation at 1 center. Impression cytology (IC) and in vivo confocal microscopy (IVCM) had not been performed to confirm the diagnosis of LSCD. She was scheduled to undergo living-related allogenic conjunctival keratolimbal transplantation per the recommendation of the consulting corneal specialists. Her brother, who is 70% histocompatibility-matched, agreed to serve as the donor. Systemic immunosuppressive therapy after surgery was also planned. However, the patient wanted a second opinion and was referred to our institute.
At presentation, her best-corrected visual acuity was light perception in the right eye and hand motions in the left eye. On slit-lamp examination, her right eye was prephthical with an edematous and opaque cornea. Her left eye had 360-degree severe thinning with uveal show at the entire limbus accompanied by peripheral pannus and corneal neovascularization that spared the central 2-mm cornea (Fig. 1A, D , G, J, M). Slit-lamp biomicroscopy of the left eye showed a smooth epithelium without fluorescein staining despite stromal haze and edema in the central cornea. Mild sectoral fluorescein staining was observed only in the extreme periphery (Fig. 1B,  E, H, K, N) . The anterior chamber was shallow, and a posterior chamber lens was present. There was no view to the posterior pole in either eye. She was on Durezol 8 times a day in both eyes and not on systemic medication for her scleritis and uveitis.
The smooth and transparent epithelial layer on the cornea indicated that the epithelium might be a corneal phenotype. Therefore, IVCM was performed to distinguish the phenotype of epithelium at the central cornea and superior, nasal, temporal, and inferior quadrants of the limbus. The confocal images obtained at the central cornea showed that the epithelial morphology was consistent with a corneal phenotype: superficial cells were loosely arranged polygonal flat cells; the morphology of wing cells was similar to that of basal cells but the cell size was bigger; and basal cells were regularly arranged with dark cytoplasm, bright cell borders, and invisible nuclei (Fig. 1C) . The morphology of FIGURE 2. AS-OCT images of a normal eye, an eye diagnosed with LSCD, and the left eye of the patient presented in this study. The corneal epithelium is hyporeflective in the normal eye, with a regular interface between the epithelium and Bowman membrane (A). Epithelial thickness at the central cornea is 55 mm in this eye. In contrast, the corneal epithelium is hyperreflective in the eye diagnosed with LSCD (B), with a decreased epithelial thickness of 37 mm. In the case described in this study, the corneal epithelium of the left eye is hyporeflective, which is similar to that of the normal eye shown in (A). However, the interface between the epithelium and underlying stroma is irregular, with hyperreflective tissue at the Bowman membrane, anterior stroma, and deep stroma (C). Epithelial thickness was measured manually at 5 locations in the central cornea with an interval of 0.5 mm because of subbasal epithelial scarring and the irregular interface between the epithelium and stroma. Mean thickness was 54 mm, and the range was 38 to 64 mm. There was severe thinning of the peripheral cornea and limbus, with the thickness down to 260 mm (D).
basal epithelial cells in the limbal regions was consistent with normal limbal epithelial cells, except those in the nasal quadrant (Fig. 1F, L, O) in which conjunctival epithelium and goblet cells were detected (Fig. 1I) . Palisades of Vogt were not detected in any of the quadrants. Basal epithelial cell density was 8265 cells/mm 2 in the central cornea, 7859 cells/ mm 2 in the superior limbus, 7391 cells/mm 2 in the inferior limbus, 8385 cells/mm 2 in the temporal limbus, and 5462 cells/mm 2 in the nasal limbus. Basal epithelial cell density, except in the nasal limbus, was within the normal range. 2, 3 Mild hyperreflectivity suggested the presence of fibrous tissues at the Bowman layer (Fig. 1C) .
Anterior segment optical coherence tomography (AS-OCT) showed that the corneal epithelium was hyporeflective and smooth despite the hyperreflective and irregular interface between the epithelium and Bowman layer (Fig. 2C) . Average thickness of central corneal epithelium was 54 mm, which was also within the normal range. 4 AS-OCT detected extreme thinning of the limbus and sclera, which was consistent with the finding from clinical examination (Fig.  2D ). Based on of the results of IVCM and AS-OCT, our diagnosis was mild sectoral LSCD without central corneal involvement. Therefore, the patient would not benefit from LSCT and surgery was canceled. The patient had persistent ocular surface inflammation, and we recommended better control of the inflammation first. Because of severe thinning down to 260 mm in the peripheral cornea and limbus, as shown by AS-OCT (Fig. 2D) , there might not be enough host tissue to safely anchor penetrating keratoplasty or a Boston type I keratoprosthesis. Lamellar keratoplasty on the peripheral cornea and limbus followed by penetrating keratoplasty or keratoprosthesis could be an option. Alternatively, penetrating keratoplasty with a small graft size might be feasible. The patient returned to New York City for management.
DISCUSSION
This case highlights the challenges of correctly diagnosing and staging LSCD by clinical examination alone. In complex cases such as this one, clinical examination is insufficient for diagnosis. Even in eyes that seem to have total LSCD at the time of clinical presentation, normal limbal epithelial cells and corneal epithelial cells may still be found through IVCM. 1 Peripheral pannus and neovascularization are often considered a typical presentation of LSCD, 5 and both are also the most prominent clinical findings in this case. However, pannus and neovascularization are not specific to LSCD and are often present in other ocular diseases without a component of LSCD. In the present case, severe scleral thinning accompanied by corneal neovascularization was mistaken as signs of total LSCD. LSCT and systemic immunosuppression were not the correct treatment and would have subjected her to the risks of surgery and life-threatening side effects of systemic immunosuppression.
The use of IC or IVCM to confirm the diagnosis of LSCD has been well established. 6, 7 IC confirms the diagnosis of LSCD by either detecting goblet cells using periodic acidSchiff staining or expression of a conjunctival epithelial marker, cytokeratin 13 or 7, on the corneal surface using immunostaining. 8, 9 The detection of goblet cells by IC was the first established diagnostic test for LSCD, but the sensitivity is low in eyes with concomitant goblet cell deficiency. 10 Use of specific cytokeratin expressed by the corneal and conjunctival epithelium has a higher sensitivity and specificity than the detection of goblet cells. 6 IVCM is a noninvasive in vivo imaging modality to diagnose LSCD with good concordance with IC using a conjunctival marker. 6 In this case, IVCM alone was sufficient to detect normal corneal epithelium on the corneal surface and normal limbal epithelium in the limbal regions without the need for IC. Detection of conjunctival epithelium and goblet cells in the nasal quadrant was apparent. Because of good concordance between IVCM and IC, IC might not be clinically necessary in cases in which IVCM is able to precisely demonstrate the distribution of the corneal and conjunctival epithelial cells on the cornea for diagnosis.
In summary, a correct diagnosis and accurate assessment of the quantity of residual limbal stem cells serve as the premise of an appropriate treatment recommendation. Clinical presentation alone is not sufficient for correctly diagnosing LSCD. Additional tests, such as IVCM or IC, are necessary to avoid unnecessary surgeries and possible harm to patients.
